Delivery Order SPE2DB20D2002-SPE2DB25FL58P
- Not listed
- The Defense Logistics Agency awarded a $2,085.12 delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,846.51 for Varivax vaccine with diluents on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-competitive delivery order with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, leveraging the company's extensive capabilities as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Varivax vaccine with diluents valued at $10,321.10 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. The contract is set to complete by July 22, 2025, and represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents under a firm fixed price contract valued at $1,053.01. This non-competitive delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,106.02 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,032.11 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 2, 2025, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,096.33 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of September 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $72,178.80 delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, executed on July 22, 2025, carries an ultimate completion date of August 12, 2025 and employs firm fixed pricing with no set-aside designation. The point of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents. This firm fixed-price delivery order, issued on July 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be fulfilled at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,212.04 by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitive award with an ultimate completion date of September 22, 2025. The contract represents a child delivery order under AmerisourceBergen's broader relationship with DLA, leveraging the company's extensive pharmaceutical distribution...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL58PDelivery Order
The Defense Logistics Agency awarded a $134,778.88 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This Varivax delivery order exemplifies the company's role in fulfilling federal vaccine procurement needs through the DLA Medical Supply Chain. AmerisourceBergen's extensive federal contracting history demonstrates its capability to manage competitively awarded contracts across multiple therapeutic domains, and this award aligns with the company's strategic positioning as a primary vendor for global pharmaceutical support to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $134.8k | 7/22/25 |